Related Experiment Video
Updated: Nov 27, 2025

Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis
Published on: October 4, 2024
[Menorrhagia during oral anticoagulant therapy]
Maja Hellfritzsch1, Anne-Mette Hvas, Margit Dueholm
1majasi@rm.dk.
Menorrhagia is a common side effect of oral anticoagulants in premenopausal women. This review details drug-specific risks and treatment options for managing heavy menstrual bleeding during anticoagulant therapy.
Area of Science:
- Pharmacology
- Gynecology
- Hematology
Background:
- Menorrhagia is a frequent complication of oral anticoagulant therapy in premenopausal women.
- Managing this bleeding complication involves balancing bleeding risks against thrombosis risks.
Purpose of the Study:
- To review the risk of menorrhagia associated with oral anticoagulant therapy.
- To highlight differences in menorrhagia risk among various anticoagulant drugs.
- To assess treatment options and provide a management algorithm for anticoagulant-associated menorrhagia.
Main Methods:
- Literature review of studies on oral anticoagulants and menorrhagia.
- Critical assessment of current treatment strategies.
- Development of a clinical management algorithm.
Main Results:
- Oral anticoagulant therapy is associated with a significant risk of menorrhagia.
- Specific anticoagulant drugs exhibit varying risks for inducing menorrhagia.
- Several treatment options exist, requiring careful consideration of individual patient factors.
Conclusions:
- Effective management of anticoagulant-associated menorrhagia is crucial.
- A structured approach, guided by a treatment algorithm, can optimize patient care.
- Further research may refine optimal therapeutic strategies for this condition.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis IV: Nursing Management
Venous Thrombosis III: Interprofessional Care
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
